Vaccines Design against Porcine Circovirus
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Veterinary Vaccines".
Deadline for manuscript submissions: 30 April 2025 | Viewed by 129
Special Issue Editors
Interests: etiology; diagnosis; vaccine development; emerging infectious diseases; re-emerging infectious diseases
Special Issues, Collections and Topics in MDPI journals
Interests: RNA virus; zoonotic pathogens; hemorrhagic fever; emerging infectious diseases; vaccine development
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Many emerging and re-emerging diseases are significant global animal and public health threats. Vaccine development has attracted much attention as the most effective means of epidemic prevention and control. This Special Issue will compile the latest advances in porcine viruses and their vaccines. For example, single or combination vaccines related to porcine circovirus, including inactivated, genetically engineered, or mRNA vaccines and adjuvants; evaluation methods for immunization efficiency; and pathogenic/attenuation mechanisms related to the porcine circovirus vaccine are welcomed.
Dr. Jianli Shi
Dr. Junki Maruyama
Dr. Takeshi Saito
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- porcine circovirus
- vaccine
- new adjuvants
- evaluation method
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
